1. Home
  2. FBIO vs JHS Comparison

FBIO vs JHS Comparison

Compare FBIO & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

N/A

Current Price

$3.28

Market Cap

104.6M

Sector

Health Care

ML Signal

N/A

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

N/A

Current Price

$11.10

Market Cap

136.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIO
JHS
Founded
2006
N/A
Country
United States
United States
Employees
101
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
104.6M
136.5M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
FBIO
JHS
Price
$3.28
$11.10
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
809.2K
17.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.71
N/A
Revenue Next Year
$49.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$10.62
52 Week High
$4.53
$12.09

Technical Indicators

Market Signals
Indicator
FBIO
JHS
Relative Strength Index (RSI) 46.73 13.58
Support Level $2.47 N/A
Resistance Level $3.96 $11.40
Average True Range (ATR) 0.23 0.11
MACD -0.01 -0.05
Stochastic Oscillator 21.12 1.35

Price Performance

Historical Comparison
FBIO
JHS

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

Share on Social Networks: